Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma".
about
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationT cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population.Adenovirus-mediated overexpression of glutathione-s-transferase mitigates transplant arteriosclerosis in rabbit carotid allograftsCardiac allograft vasculopathy: current knowledge and future direction.Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patientsGraft vessel disease following heart transplantation: a systematic review of the role of statin therapy.Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cellsIFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cellsReduced progression of cardiac allograft vasculopathy with routine use of induction therapy with basiliximabEffect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation.ADMA: its role in vascular disease.Nitric oxide homeostasis as a target for drug additives to cardioplegiaRibonuclease (RNase) Prolongs Survival of Grafts in Experimental Heart Transplantation.Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targetsInterleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection.Should we consider patients with coexistent hepatitis B or C infection for orthotopic heart transplantation?Clinical utility of intravascular ultrasound in the assessment of coronary allograft vasculopathy: a review.Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factors.Endothelial dysfunction and cardiac allograft vasculopathy.Endothelium and regulatory inflammatory mechanisms during organ rejection.Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis.Hypoxia increases membranal and secreted HLA-DR in endothelial cells, rendering them T-cell activators.HHEX: A Crosstalker between HCMV Infection and Proliferation of VSMCs.Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells.Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.Limitation of myocardial and endothelial injury of the rat heart graft after preservation with Centre de Résonance Magnétique Biologique et Médicale (CRMB) solution.Avoidance of Profound Hypothermia During Initial Reperfusion Improves the Functional Recovery of Hearts Donated After Circulatory Death.Influence of smoking cessation on carotid artery wall elasticity evaluated by echo-tracking.Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
P2860
Q21131166-0B1DCAFA-6E73-4CB1-90E5-3253784BDB76Q33328649-AD267956-1289-4728-8996-D5B9B8D0E3BBQ33817939-77B13C13-C41A-46E5-B297-F6F7302CCA06Q33860323-33EAE00A-4DF8-4442-8136-61DA80FD830BQ33891755-1C1A54A0-C09F-47EF-ABF1-A53F64AA83B2Q34257142-9799B6DF-FD32-4709-8CAB-6459B03E0350Q35139244-EC3F73F3-346A-41BC-B29A-67165C542476Q35613184-F997019D-CB0A-468B-B2EA-A0BB830DFAD1Q35638639-CEE4C06A-EB1B-4898-AEE3-79C414244D28Q36024257-205C8299-2BBA-4678-AC2E-993AEF433415Q36302824-078796DA-5F80-4D93-9E8A-53293D00C9BBQ36380994-EF2357F4-30EA-4C3D-AA90-35773779A975Q36814343-54E129D9-0667-485D-BC8C-7BED0BF4BD5EQ36956810-B7DD2964-D712-4CFD-8DA6-48C32389AEDAQ36993722-5AF7A19F-ECE4-484A-921A-F249CE95147FQ37019593-C2C31D87-C0B8-4551-BD40-11B3CB48ED8BQ37338207-F71DD1A6-8CEF-43B7-98AA-72D74B32B4ADQ37804420-465B6839-BD83-4EDB-9087-467FF7609CBEQ37969222-D3F7A775-1EBE-47A5-980F-70A61009151DQ38058477-E2B6A0FD-4BAC-4E6B-8F9F-F41D397CFCB5Q38103486-C4A0EEBD-E3FF-4725-A2CB-FB448E0FEC61Q38681523-63C5081F-DDD5-49D9-A869-E3C4036D7FC6Q39497103-EBF37112-4624-423E-986C-978504D78067Q40410947-05BE714F-06F4-4277-B508-7534D644B071Q43169563-1814A2AA-F92A-49DF-9448-09D463AC528DQ46231960-E6EFE7F6-393E-4D04-BC5C-357790EF77B3Q46881711-898747E2-457A-4087-A0D2-305233FBCBE8Q47602043-89932094-9DA1-4724-82D8-55DD1863FBE1Q48792659-C0767F87-CA2A-4451-BBE2-263CE7A7D4AFQ50485357-A2A22AE2-3B44-442C-8363-CCE3506B5DE7
P2860
Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma".
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cardiac allograft vasculopathy ...... ding to transplant "atheroma".
@ast
Cardiac allograft vasculopathy ...... ding to transplant "atheroma".
@en
type
label
Cardiac allograft vasculopathy ...... ding to transplant "atheroma".
@ast
Cardiac allograft vasculopathy ...... ding to transplant "atheroma".
@en
prefLabel
Cardiac allograft vasculopathy ...... ding to transplant "atheroma".
@ast
Cardiac allograft vasculopathy ...... ding to transplant "atheroma".
@en
P1433
P1476
Cardiac allograft vasculopathy ...... ding to transplant "atheroma".
@en
P2093
Hannah A Valantine
P304
P356
10.1097/01.TP.0000080981.90718.EB
P577
2003-09-01T00:00:00Z